Kyle Chenet

Vice President, Corporate Development
Liquidia Technologies, Inc

Mr. Chenet joined Liquidia in 2007 from Biolex Therapeutics where he was focused on executing new partnerships with pharmaceutical companies intent on leveraging Biolex' protein engineering and production technology to enable new therapeutic protein products. Prior to joining Biolex, Mr. Chenet was a Director in GlaxoSmithKline's Worldwide Business Development where he was responsible for evaluating and negotiating worldwide licensing agreements across multiple therapeutics areas. Prior to GSK, Mr. Chenet spent several years as a manager at Abbott Laboratories. Mr. Chenet has a M.B.A. from Stanford University and a B.S.E from the University of Michigan.